Dr. Bharat Bhushan
- Last Updated On :
|
Name |
Dr. Bharat Bhushan |
 |
|
Designation |
Scientist-II |
|
|
|
This email address is being protected from spambots. You need JavaScript enabled to view it. This email address is being protected from spambots. You need JavaScript enabled to view it. |
|
|
Phone |
29575401 |
|
|
Contact Details |
Room No. 401, Department of Medical Oncology, DR BRAIRCH, AIIMS, New Delhi. |
Research Experience
Six years of research experience in hematological malignancies. Worked on project funded by ICMR based on flow cytometric assays to evaluate prognosis and patients response to chemotherapy in acute leukemia (2003-2006) and worked as an Independent ICMR-SRF on a project based on the role of NF-kBpathwayin acute leukemia (2006-2009).
Industrial Experience
A total six year of industrial experience at OncQuest (Diagnostic Lab), New Delhiand at LabLegacy, Ghaziabad (2009 - 2015).
Research Interest
Cancer Sem Cell Research, Cancer Immunotherapy, Role of NFkB pathway in the pathogenesis of Hematological Malignancies (Leukemia).
Awards / Fellowships
Indian Council of Medical Research (ICMR) – JRF (2001)
Indian Council of Medical Research (ICMR) – SRF (2006)
Selected Publications in International Journals and Conference Proceedings
1. Relation of cell viability and apoptosis with clinical remission following induction chemotherapy in ALL and AML.Bhushan B, Ahuja D, Verma S, Saluja S, Siddiqui S, Kapur S.J ExpClin Cancer Res. 2007 Sep;26(3):313-21.
2. Aberrant phenotypes in childhood and adult acute leukemia and its association with adverse prognostic factors and clinical outcome.Bhushan B, Chauhan PS, Saluja S, Verma S, Mishra AK, Siddiqui S, Kapur S.ClinExp Med. 2010 Mar;10(1):33-40.
3. Mutation of FLT3 gene in acute myeloid leukemia with normal cytogenetics and its association with clinical and immunophenotypic features.Chauhan PS, Bhushan B, Mishra AK, Singh LC, Saluja S, Verma S, Gupta DK, Mittal V, Chaudhry S, KapurS.MedOncol. 2011 Jun;28(2):544-51.
4. Association of glutathione S-transferase, EPHX, and p53 codon 72 gene polymorphisms with adult acute myeloid leukemia.Chauhan PS, Ihsan R, Yadav DS, Mishra AK, Bhushan B, Soni A, Kaushal M, Devi TR, Saluja S, Gupta DK, Mittal V, Saxena S, Kapur S.DNA Cell Biol. 2011 Jan;30(1):39-46.
5. Expression of genes related to multiple drug resistance and apoptosis in acute leukemia: response to induction chemotherapy.Chauhan PS, Bhushan B, Singh LC, Mishra AK, Saluja S, Mittal V, Gupta DK, Kapur S.ExpMolPathol. 2012 Feb;92(1):44-9
6. NF-kB signaling pathway in acute leukemia: A study on expression of cell survival and proliferative genes by Real Time RT-PCR. Bhushan B, Chauhan P S, et. al. Proceedings of 13th Human Genome Meeting (HGM 2008), Hyderabad, India, 2008.
7. Flowcytometric in vitro chemosensitivity assay: A tool to predict clinical response in acute leukemia. Bhushan B,Saluja S,et. al. Proceedings of 18th International Congress on Anti Cancer Treatment (ICACT 2007), France, 2007.
